Erasca (ERAS) Receivables - Other (2021 - 2022)

Erasca's (ERAS) quarterly Receivables - Other came in at $100000.0 in Q3 2022, little changed on a QoQ basis from $100000.0 in Q2 2022.

Erasca (ERAS) Receivables - Other (2021 - 2022) Analysis & Trends

Erasca (ERAS) has 2 years of Receivables - Other data on file, last reported at $100000.0 in Q3 2022.

Quarterly Receivables - Other changed N/A year-over-year to $100000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $100000.0 (changed N/A YoY) and the FY2021 annual result came in at $100000.0, changed N/A from the prior year.
Receivables - Other held at $100000.0 in Q3 2022, from $100000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $100000.0 in Q4 2021 to a low of $100000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Erasca	6.43 Bn	6.16 Bn	-

Download Data